Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells, as well as other medical devices. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wounds, and maxillo-facial applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Laboratory apparatus & furniture
Sub-IndustryN/A
SectorComputer and Technology
SymbolNASDAQ:MSON
CUSIPN/A
Phone631-694-9555
Debt
Debt-to-Equity RatioN/A
Current Ratio5.48
Quick Ratio4.24
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$27.27 million
Price / Sales5.95
Cash FlowN/A
Price / CashN/A
Book Value$3.12 per share
Price / Book5.53
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-1,680,000.00
Net Margins-17.36%
Return on Equity-1.68%
Return on Assets-1.42%
Miscellaneous
Employees92
Outstanding Shares9,400,000
Market Cap$163.17 million
Misonix (NASDAQ:MSON) Frequently Asked Questions
What is Misonix's stock symbol?
Misonix trades on the NASDAQ under the ticker symbol "MSON."
How were Misonix's earnings last quarter?
Misonix, Inc. (NASDAQ:MSON) posted its earnings results on Monday, May, 7th. The medical equipment provider reported $0.23 EPS for the quarter. The medical equipment provider earned $12.44 million during the quarter. Misonix had a negative net margin of 17.36% and a negative return on equity of 1.68%. View Misonix's Earnings History.
When is Misonix's next earnings date?
Who are some of Misonix's key competitors?
Some companies that are related to Misonix include CEVA (CEVA), XP Power (XPP), Real Matters (REAL), GB Group (GBG), QuinStreet (QNST), Mistras Group (MG), Donnelley Financial Solutions (DFIN), ChipMOS Technologies (IMOS), Materialise (MTLS), Solium Capital (SUM), Photronics (PLAB), Tucows (TCX), Aurinia Pharmaceuticals (AUP), Vishay Precision Group (VPG) and Accesso Technology Group (ACSO).
Who are Misonix's key executives?
Misonix's management team includes the folowing people:
- Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 48)
- Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 62)
- Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 51)
- Mr. Richard A. Zaremba, Special Projects Mang. (Age 63)
- Mr. Dan Voic, VP of R&D and Engineering (Age 56)
Has Misonix been receiving favorable news coverage?
Media stories about MSON stock have trended somewhat positive on Sunday, according to Accern. The research group ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Misonix earned a media and rumor sentiment score of 0.06 on Accern's scale. They also assigned media headlines about the medical equipment provider an impact score of 47.84 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future. View Recent Headlines for Misonix.
Who are Misonix's major shareholders?
Misonix's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (4.01%), Renaissance Technologies LLC (2.23%), WealthTrust Axiom LLC (0.44%) and BlackRock Inc. (0.27%). Company insiders that own Misonix stock include Joseph P Dwyer, Patrick A Mcbrayer, Stavros G Vizirgianakis and Thomas M Patton. View Institutional Ownership Trends for Misonix.
Which major investors are selling Misonix stock?
Which major investors are buying Misonix stock?
MSON stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and BlackRock Inc.. Company insiders that have bought Misonix stock in the last two years include Joseph P Dwyer, Patrick A Mcbrayer, Stavros G Vizirgianakis and Thomas M Patton. View Insider Buying and Selling for Misonix.
How do I buy shares of Misonix?
Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Misonix's stock price today?
One share of MSON stock can currently be purchased for approximately $17.25.
How big of a company is Misonix?
Misonix has a market capitalization of $163.17 million and generates $27.27 million in revenue each year. Misonix employs 92 workers across the globe.
How can I contact Misonix?
Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.
MarketBeat Community Rating for Misonix (NASDAQ MSON)
MarketBeat's community ratings are surveys of what our community members think about Misonix and other stocks. Vote "Outperform" if you believe MSON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MSON will underperform the S&P 500 over the long term. You may vote once every thirty days.
